We are live on ! Find out more
SA

Syntax Advisors Portfolio holdings

AUM $114M
1-Year Est. Return 15.11%
This Fund
S&P 500
This Quarter Est. Return
-12.39%
1 Year Est. Return
+15.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$39K
Cap. Flow
+$16.2M
Cap. Flow %
13.58%
Top 10 Hldgs %
51.22%
Holding
234
New
13
Increased
154
Reduced
49
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 10.13%
2 Consumer Staples 9.94%
3 Consumer Discretionary 7.65%
4 Healthcare 7.15%
5 Utilities 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMB icon
76
Williams Companies
WMB
$90.7B
$305K 0.26%
9,761
-432
-4% -$14.9K
NEM icon
77
Newmont
NEM
$95.2B
$303K 0.25%
5,085
+857
+20% +$60.6K
NKE icon
78
Nike
NKE
$64.5B
$303K 0.25%
2,964
+973
+49% +$115K
KMI icon
79
Kinder Morgan
KMI
$72.5B
$300K 0.25%
17,886
-81
-0.5% -$1.52K
UHS icon
80
Universal Health Services
UHS
$9.12B
$299K 0.25%
2,968
+810
+38% +$101K
SYF icon
81
Synchrony
SYF
$24.7B
$298K 0.25%
10,805
+1,526
+16% +$53K
NUE icon
82
Nucor
NUE
$52.5B
$295K 0.25%
2,830
+424
+18% +$57.4K
PVH icon
83
PVH
PVH
$3.56B
$295K 0.25%
5,187
+705
+16% +$48.7K
OKE icon
84
Oneok
OKE
$58.9B
$292K 0.25%
5,255
+333
+7% +$21.6K
HCA icon
85
HCA Healthcare
HCA
$82.2B
$291K 0.24%
1,734
+515
+42% +$111K
CNC icon
86
Centene
CNC
$32.5B
$290K 0.24%
3,424
+305
+10% +$25.3K
UNH icon
87
UnitedHealth
UNH
$383B
$288K 0.24%
561
+23
+4% +$11.6K
HUM icon
88
Humana
HUM
$47.8B
$286K 0.24%
610
-1
-0.2% -$445
BKR icon
89
Baker Hughes
BKR
$54.7B
$279K 0.23%
9,659
+1,022
+12% +$34.6K
MOH icon
90
Molina Healthcare
MOH
$12B
$275K 0.23%
982
+151
+18% +$45.6K
ELV icon
91
Elevance Health
ELV
$82.9B
$272K 0.23%
564
+4
+0.7% +$1.98K
MNST icon
92
Monster Beverage
MNST
$93.4B
$272K 0.23%
5,858
-4,132
-41% -$180K
BBWI icon
93
Bath & Body Works
BBWI
$4.13B
$271K 0.23%
10,056
+3,111
+45% +$135K
MRNA icon
94
Moderna
MRNA
$23.6B
$270K 0.23%
1,889
+227
+14% +$32.4K
TAP icon
95
Molson Coors Class B
TAP
$7.8B
$266K 0.22%
4,887
+89
+2% +$4.78K
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$122B
$266K 0.22%
945
-27
-3% -$7.23K
HAL icon
97
Halliburton
HAL
$29.3B
$264K 0.22%
8,404
-287
-3% -$10.7K
GS icon
98
Goldman Sachs
GS
$311B
$263K 0.22%
885
+141
+19% +$43.9K
TMUS icon
99
T-Mobile US
TMUS
$212B
$263K 0.22%
1,954
-4
-0.2% -$522
BF.B icon
100
Brown-Forman Class B
BF.B
$12.1B
$262K 0.22%
3,729
-169
-4% -$11.3K

Similar funds

Syntax Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Syntax Advisors held 234 positions worth $119M, down 0.03% from $119M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Syntax Advisors deployed $16.2M of net new capital in Q2 2022, opening 13 new positions and adding to 154 existing holdings. Its largest new stake was Keurig Dr Pepper: 7,196 shares worth $255K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Valero Energy, an estimated $199K trimmed.

  • Syntax Advisors's largest Q2 2022 buy was Keurig Dr Pepper: 7,196 shares worth $255K.
  • Syntax Advisors added most to Syntax Stratified LargeCap ETF in Q2 2022, an estimated $10.4M increase.
  • Syntax Advisors's biggest Q2 2022 reduction was Valero Energy, cutting an estimated $199K.
  • Syntax Advisors fully exited NXP Semiconductors in Q2 2022, selling an estimated $270K.
  • Syntax Advisors's ten largest holdings make up 51% of its $119M portfolio in Q2 2022.
  • Syntax Advisors opened 13 new positions and closed 18 in Q2 2022.
  • Syntax Advisors's portfolio value fell 0.03% quarter-over-quarter to $119M.

Based on Syntax Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.